Page 173 - Contributed Paper Session (CPS) - Volume 2
P. 173

CPS1494 Senthilvel V. et al.
            there is a need for regular screening check-up schedule of retinopathy with a
            properly  trained  ophthalmologist  and  control  the  important  risk  factors  to
            prevent diabetic retinopathy or to prolong or to maintain or retain in their
            same stage of DR or to escape from the vision loss.

            Acknowledgment:  Authors are very much thankful to the Medical Director,
            HOD and the study participants.

            References
            1.  World Health Organization: Diabetes Mellitus.  Available on:
                 http://www.who.int/mediacentre/factsheets/fs138/en/
            2.  The Royal College of Ophthalmologists: Diabetic Retinopathy Guidelines.
                 Section 1:  Terminology and Disease Definition. Available on:
                 https://www.rcophth.ac.uk/wp-content/uploads/2014/12/2013-SCI-301-
                 FINAL-DR-GUIDELINES-DEC-2012-updated-July-2013.pdf
            3.  The Diabetic Retinopathy Study Research Group (1981).
                 Photocoagulation treatment of proliferative diabetic retinopathy:  Clinical
                 application of Diabetic Retinopathy Study (DRS) findings, DRS Report
                 Number 8.  Ophthalmology;88(7):583-600.
                 DOI:  http://doi.org/10.1016/So161-6420(81)34978-1
            4.  Early Treatment Diabetic Retinopathy Study Research Group (1991).
                 Early phogocoagulation for diabetic retinpathy.  ETDRS report number 9.
                 Ophthalmology;98(Suppl. 5):766-785.
                 DOI: https://doi.org/10.1016/S0161-6420(13)38011-7
            5.  Wild S, Roglic G, Green A, Sincree R, King H (2004).  Global prevalence of
                 diabetes:  Estimates for the year 2000 and projections for 2030.  Diabetes
                 Care;27(5):1047-1053.   PMID:  1511519
            6.  Cheung N, Mitchell P, Wong TY (2010). Diabetic Retinopathy.
                 Lancet;376(9735):124-136.  PMID: 20580421
                 DOI: https://doi.org/10.1016/S0140-6736(09)62124-3
            7.  Diabetic Retinopahty: Diabetic Retinopahty PPP – Updated (2017). AAO
                 PPP Retina/Vitreous Panel, Hoskins Center for Quality Eye Care Avaiable
                 on: https://www.aao.org/preferred-practice-pattern/diabetic-
                 retinopathy-ppp-updated-2017
            8.  Tapp RJ, Shaw JE, Harper CA et al (2003).  The prevalence and factors
                 associated with Diabetic Retinopathy in the Australian population.
                 Diabetes Care;26:1731-1737 PMID: 12766102
            9.  Chakrabarti R, Harper CA, Keeffe JE (2012).  Diabetic Retinopathy
                 management guidelines. Exper Rev. Ophthalmol;7(5):417-439.
                 DOI: https://doi.org/10.1586/eop.12.52
            10.  Raman R, Ganesan S, Pal SS et al (2014).  Prevalence and risk factors for
                 diabetic retinopathy in rural India.  Sankara Nethralaya Diabetic

                                                               162 | I S I   W S C   2 0 1 9
   168   169   170   171   172   173   174   175   176   177   178